Keeping Up with GAIA-BT
March 30, 2026 | GAIA-BT
On March 30th (Monday), GAIA-BT and EDGENE, a biotech developing therapeutics for mitochondrial genetic disorders, signed an MOU for joint R&D collaboration.
PREVIOUS
🡨 GAIA-BT, Accelerate Your Bio R&D with GAIA-Agents Today!
☰
NEXT
GAIA-BT Signs MOU with Jeju Technopark for AI-driven Jeju BIO 🡪